JANSSEN PHARMACEUTICA NV
- Country
- Belgium
- Type
- Beneficiary
- Website
- www.janssenpharmaceutica.be
- Grants received
- 100
Funding record
- 100 grants on record
- €10,443,748.99 awarded in total
- 2008–2025 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
78 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- ASTRAZENECA AB
- BAYER AKTIENGESELLSCHAFT
- ELI LILLY AND COMPANY LTD
- KATHOLIEKE UNIVERSITEIT LEUVEN
- NOVARTIS PHARMA AG
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
- GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED
- SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT
Calls from this organisation
No published calls from this organisation.
Grants received
- Research in Europe and Diversity Inclusion
- Crystallisation towards efficient and sustainable biomanufacturing
- Patient-Centric blOod saMpling FOr impRoved healThcare (Project-COMFORT)
- IMAGING FOR PATIENT BENEFIT IN ARTHRITIS
- Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research
- Synthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applications
- Ion Mobility Mass Spectrometry Training Network
- Developing broad-spectrum antiviral drugs for pandemic preparedness
- Base metal-catalytic cross-coupling methodologies towards sustainability
- IMAGING AND ADVANCED GUIDANCE FOR WORKFLOW OPTIMIZATION IN INTERVENTIONAL ONCOLOGY
- Clinical Trials Community Africa Network
- Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance
- Doctoral network for microprocess engineering for electrosynthesis - new synthesis concepts for pharmaceutical/ fine chemical industry
- Oral delivery of encapsulated RNA nanotherapeutics for targeted treatment of ileal Crohn's disease
- DIgital health in Circular Economy
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.